Stryker Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Stryker ha aumentado sus beneficios a una tasa media anual de 1%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 13.4% anual. Los ingresos han ido creciendo a una tasa media de 8.7% al año. La rentabilidad financiera de Stryker es de 17.5%, y sus márgenes netos son de 16%.

Información clave

1.0%

Tasa de crecimiento de los beneficios

0.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	8.9%
Tasa de crecimiento de los ingresos	8.7%
Rentabilidad financiera	17.5%
Margen neto	16.0%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Jun 17

Stryker: Good Prospects

Jun 14

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

May 24

Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?

May 01

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Apr 18

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Apr 06

Is Stryker (NYSE:SYK) Using Too Much Debt?

Feb 27

Stryker: Typically Excellent, Typically Expensive

Feb 16

Stryker Has A Slowing FCF Conversion And No Plans Of Share Buyback

Feb 07

If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity

Feb 02

Stryker Non-GAAP EPS of $3.00 beats by $0.16, revenue of $5.2B beats by $230M

Jan 31

Stryker initiated at sector weight by KeyBanc on limited upside potential

Jan 25

Stryker: Excellent Recent And Continuing Performance

Jan 09

Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital

Jan 08

At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Dec 26

Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Dec 12

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Stryker. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:SYK Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 24	20,963	3,361	7,051	1,330
31 Dec 23	20,498	3,165	6,943	1,301
30 Sep 23	19,885	2,585	6,678	1,451
30 Jun 23	19,455	2,709	6,491	1,454
31 Mar 23	18,952	2,627	6,278	1,459
31 Dec 22	18,449	2,358	6,114	1,454
30 Sep 22	17,948	2,457	6,014	1,372
30 Jun 22	17,629	2,079	5,925	1,322
31 Mar 22	17,430	2,015	5,929	1,281
31 Dec 21	17,108	1,994	5,752	1,235
30 Sep 21	16,669	1,900	5,525	1,159
30 Jun 21	16,246	2,083	5,297	1,095
31 Mar 21	14,716	1,408	4,900	1,018
31 Dec 20	14,351	1,599	4,759	984
30 Sep 20	14,220	1,756	4,766	983
30 Jun 20	14,070	1,601	4,824	987
31 Mar 20	14,956	2,164	4,995	1,000
31 Dec 19	14,884	2,083	4,968	971
30 Sep 19	14,549	3,426	4,970	938
30 Jun 19	14,204	3,550	4,914	913
31 Mar 19	13,876	3,522	4,864	883
31 Dec 18	13,601	3,553	4,808	862
30 Sep 18	13,276	1,236	4,687	846
30 Jun 18	13,040	1,080	4,556	823
31 Mar 18	12,730	1,019	4,484	799
31 Dec 17	12,444	1,020	4,380	787
30 Sep 17	12,130	1,779	4,239	771
30 Jun 17	11,957	1,700	4,167	757
31 Mar 17	11,785	1,689	4,076	748
31 Dec 16	11,325	1,647	3,941	715
30 Sep 16	10,883	1,659	3,828	690
30 Jun 16	10,470	1,605	3,703	661
31 Mar 16	10,062	1,617	3,591	632
31 Dec 15	9,946	1,439	3,511	625
30 Sep 15	9,849	1,177	3,445	614
30 Jun 15	9,818	933	3,417	612
31 Mar 15	9,749	669	3,381	616
31 Dec 14	9,675	515	3,356	614
30 Sep 14	9,525	641	2,851	600
30 Jun 14	9,287	687	3,147	583
31 Mar 14	9,136	772	3,305	557
31 Dec 13	9,021	1,006	3,345	536
30 Sep 13	8,891	890	4,046	526
30 Jun 13	8,792	1,140	3,700	504

Ingresos de calidad: SYK tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (15.4%) de SYK son superiores a los del año pasado (12.8%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de SYK han crecido un 1% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de SYK en el último año (34.2%) supera su media de 5 años (-3.8% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de SYK en el último año (34.2%) superó al de la industria Medical Equipment 3.3%.

Stryker Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Third quarter 2023 earnings: EPS misses analyst expectations

Stryker Corporation to Report Q3, 2023 Results on Nov 02, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Recent updates

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Insufficient new directors

Stryker: Mako Shoulder And Spine Launches Are On The Way

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of US$0.80 per share at 1.0% yield

Stryker Corporation (NYSE:SYK) executed a binding offer to acquire Serf from SAS Menix.

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Declares Quarterly Dividend, Payable on January 31, 2024

VP & CFO exercised options and sold US$1.6m worth of stock

Why Stryker Is An Awesome Healthcare Compounder

Chairman notifies of intention to sell stock

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS misses analyst expectations

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Stryker: Don't Buy This Dividend Champion (Yet)

Stryker to Showcase Q Guidance System with Spine Guidance Software

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Stryker Corporation to Report Q3, 2023 Results on Nov 02, 2023

Is Stryker (NYSE:SYK) A Risky Investment?

Upcoming dividend of US$0.75 per share at 1.0% yield

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker Corporation Releases Its Next-Generation of Advanced Surgical Cameras

Stryker’S Pangea Systems Receive Food & Drug Administration Clearance

Key Executive recently sold US$1.4m worth of stock

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Stryker Corporation Provides Earnings Guidance for the Year 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Stryker Corporation to Report Q2, 2023 Results on Aug 03, 2023

Upcoming dividend of US$0.75 per share at 1.0% yield

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Stryker: Good Prospects

Independent Director recently sold US$139k worth of stock

Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

Independent Director recently sold US$286k worth of stock

Independent Director notifies of intention to sell stock

Price target increased by 7.5% to US$310

Stryker Corporation Declares Quarter Dividend, Payable on July 31, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Desglose de ingresos y gastos
Beta